Trials24 GmbH
Booth number: 180-08
trials24.com
About us
Trials24 accelerates patient recruitment for clinical trials globally, helping CROs and biopharmaceutical companies find patients beyond their sites’ reach. We commonly contribute 20-65% of all randomized patients and shorten the recruitment timeline by 6 months or more.
Our approach centers around online patient recruitment, with a rigorous triple-prequalification process of patients before referral. The result: sites screen up to 40% of Trials24’s referrals.
To ensure the predictability of our campaign’s successes, timelines, and costs, Trials24 offers a Patient-Reported Feasibility Study approach based on real-world data (RWD). We measure the patient population’s eligibility rate specific to the study protocol and build a recruitment cost model that projects patient enrollment costs. This RWD-based scientific approach ensures our customers know our campaign will be ROI-positive before implementation.
Address
Denninger Str. 30
81679 Munich
Germany
E-mail: info@trials24.com
Phone: +49 89 215374990
Internet: trials24.com
Contact person:
Online Patient Recruitment
We accelerate patient recruitment with online awareness campaigns by reducing recruitment time by 6 months or more, often providing 20-65% of all randomized patients. With an inbound call acceptance rate higher than 90% and an average of 4 to 11 touchpoints per patient, our country-specific call center ensures high-quality participant selection and high patient engagement rates in various therapeutic areas.
Patient-Reported Feasibility Study
Trials24 offers Patient-Reported Feasibility Studies based on real-world data (RWD) to ensure online recruitment success, cost predictability, and timeline consistency. We build a recruitment cost model that projects patient enrollment costs by measuring the patient population’s eligibility rate specifically to the study protocol. Our RWD-based scientific approach assures sponsors and CROs that our campaign will be ROI-positive before implementation.
